MedAvail Holdings, Inc.
MDVLQ
$0.0001
$0.000.00%
| Weiss Ratings | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -72.50 | |||
| Price History | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -80.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -99.99% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -99.99% | |||
| 52-Week Low % Change | 9,900.00% | |||
| Price | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.41 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 26, 2024 | |||
| 52-Week High Price (Date) | Mar 15, 2024 | |||
| Valuation | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 161.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -28.59 | |||
| Earnings Per Share Growth | -55.78% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -0.51 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | 0.45 | |||
| Enterprise Value/EBIT | 0.38 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.80M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905 812 0023 | |||
| Address | 4720 East Cotton Gin Loop Phoenix, AZ 85040 | |||
| Website | medavail.com | |||
| Country | United States | |||
| Year Founded | 2015 | |||
| Profitability | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -132.99% | |||
| Profit Margin | -192.97% | |||
| Management Effectiveness | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -47.89% | |||
| Return on Equity | -- | |||
| Income Statement | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 23.84M | |||
| Total Revenue (TTM) | 23.84M | |||
| Revenue Per Share | $13.26 | |||
| Gross Profit (TTM) | 1.39M | |||
| EBITDA (TTM) | -27.01M | |||
| EBIT (TTM) | -31.70M | |||
| Net Income (TTM) | -46.00M | |||
| Net Income Avl. to Common (TTM) | -46.00M | |||
| Total Revenue Growth (Q YOY) | -25.41% | |||
| Earnings Growth (Q YOY) | -1.46% | |||
| EPS Diluted (TTM) | -28.59 | |||
| EPS Diluted Growth (Q YOY) | 61.86% | |||
| Balance Sheet | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 14.36M | |||
| Cash Per Share (Q) | $7.99 | |||
| Total Current Assets (Q) | 27.05M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 23.05M | |||
| Current Ratio (Q) | 6.508 | |||
| Book Value Per Share (Q) | $14.28 | |||
| Total Assets (Q) | 29.91M | |||
| Total Current Liabilities (Q) | 4.16M | |||
| Total Debt (Q) | 2.26M | |||
| Total Liabilities (Q) | 6.86M | |||
| Total Common Equity (Q) | 23.05M | |||
| Cash Flow | MDVLQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -606.00K | |||
| Cash from Financing (TTM) | 17.30M | |||
| Net Change in Cash (TTM) | -14.84M | |||
| Levered Free Cash Flow (TTM) | -18.70M | |||
| Cash from Operations (TTM) | -31.54M | |||
